Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 406

Results For "CENT"

4418 News Found

CDSCO approves Syntellix implants
News | October 08, 2021

CDSCO approves Syntellix implants

This opens up a huge market for the company’s Magnezis implants in India


Lilac Insights launches mental health platform AtEase
Healthcare | October 08, 2021

Lilac Insights launches mental health platform AtEase

The platform will provide a safe and nurturing space for women, and non-binary individuals


Lincoln Pharma gets Australian TGA approval
News | October 08, 2021

Lincoln Pharma gets Australian TGA approval

The company plans to expand its portfolio in regulated markets aggressively


WHO gives its go-ahead for first-ever malaria vaccine
Drug Approval | October 07, 2021

WHO gives its go-ahead for first-ever malaria vaccine

It recommends using the vaccine to prevent the spread of the disease


Janssen announces novel mechanism that shows promise against dengue
Biotech | October 07, 2021

Janssen announces novel mechanism that shows promise against dengue

Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats


PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel
Medical Device | October 07, 2021

PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel

RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus


Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D
News | October 06, 2021

Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D

The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20


WHO decision on Covaxin approval next week
Drug Approval | October 06, 2021

WHO decision on Covaxin approval next week

Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021


EMA authorises booster dose of Moderna’s Spikevax
Drug Approval | October 06, 2021

EMA authorises booster dose of Moderna’s Spikevax

A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects


Ayushman Bharat PM-JAY rates revised
Public Health | October 06, 2021

Ayushman Bharat PM-JAY rates revised

The rates for over 400 procedures were revised